Region Skane
- Address
- lock Available on a paid plan
Analytical, Diagnostic and Therapeutic Techniques and Equipment – Diagnosis
At Region Skane the focus is on improving diagnostic tools, such as PET imaging for neurodegeneration and rapid HPV testing, aiming to enhance early detection and patient management.
- Tau PET imaging for Alzheimer’s disease
- Integrated HPV screening in cervical program
- Diagnostic accuracy of iron deficiency tests
The department collaborates with local primary care to translate these technologies into routine clinical practice.
Hemic and Lymphatic Diseases
Researchers are evaluating novel combination therapies for mantle cell lymphoma, seeking to extend progression‑free survival and offer less toxic alternatives.
- Rituximab/Ibrutinib versus chemotherapy
- Biomarker studies in lymphoma
- Patient‑reported outcomes in blood cancers
The trial team includes seven investigators, reflecting a strong multidisciplinary effort.
Neoplasms
The site conducts studies on cervical cancer prevention through coordinated HPV vaccination and screening, targeting a rapid reduction of infection rates nationwide.
- Population‑level HPV vaccination impact
- Screening program effectiveness
- Long‑term cancer incidence monitoring
Findings will guide public‑health policies across Sweden.
Respiratory Tract Diseases
A randomized trial investigates whether a short course of antibiotics can shorten symptom duration in severe group A streptococcal‑negative tonsillitis, informing primary‑care prescribing habits.
- Antibiotic versus no‑treatment for tonsillitis
- Centor score‑guided management
- Safety outcomes in acute throat infections
Results are expected to support evidence‑based guidelines for clinicians.
Environment and Public Health
Studies address nutritional deficiencies, evaluating alternate‑day iron supplementation in adolescent girls to combat iron deficiency anemia and improve overall health.
- Feasibility of alternate‑day iron dosing
- Diagnostic performance of iron biomarkers
- Adherence strategies for teens
The project integrates community outreach to ensure broad participation.
Not possible to specify
Ongoing exploratory work examines the safety and rapid‑acting antidepressant potential of ketamine‑derived compounds as adjuncts to standard therapy for major depressive disorder.
- One‑week ketamine adjunct trial
- Mood rating scale outcomes
- Side‑effect monitoring
This line of research may open new avenues for treatment‑resistant depression.
Mental Disorders
Clinical trials test the efficacy of pramipexole in reducing anhedonia among patients with major depression, aiming to enhance symptom relief beyond conventional antidepressants.
- Pramipexole for anhedonia
- Neurochemical target validation
- Quality‑of‑life assessments
Collaboration with psychiatric services ensures comprehensive patient care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 7 therapeutic areas and 15 of 21 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Region Skane3active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Region Skane7trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Region Skane
lock Showing 1 of 9 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Adjunctive Pramipexole in Bipolar Depression with Anhedonia: Phase III Double‑Blind Randomized Controlled Trial | Region Skane | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 21 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pramipexole | 3 | Unknown | 2022-10-16 | 2023-04-21 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.